Astrotech (NASDAQ:ASTC) Stock Crosses Below 200-Day Moving Average – Here’s Why

Astrotech Corporation (NASDAQ:ASTCGet Free Report)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.65 and traded as low as $2.35. Astrotech shares last traded at $2.3950, with a volume of 1,517 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Astrotech in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Astrotech has an average rating of “Sell”.

View Our Latest Stock Report on Astrotech

Astrotech Stock Down 1.4%

The company has a market capitalization of $4.22 million, a price-to-earnings ratio of -0.29 and a beta of 0.38. The company has a 50 day simple moving average of $2.96 and a 200 day simple moving average of $3.65.

Astrotech (NASDAQ:ASTCGet Free Report) last released its quarterly earnings data on Friday, February 13th. The aerospace company reported ($2.34) EPS for the quarter. The firm had revenue of $0.15 million during the quarter. Astrotech had a negative return on equity of 68.53% and a negative net margin of 1,163.89%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Astrotech stock. Susquehanna International Group LLP acquired a new position in shares of Astrotech Corporation (NASDAQ:ASTCFree Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 13,539 shares of the aerospace company’s stock, valued at approximately $66,000. Susquehanna International Group LLP owned 0.77% of Astrotech as of its most recent SEC filing. 24.35% of the stock is owned by hedge funds and other institutional investors.

Astrotech Company Profile

(Get Free Report)

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.

Featured Stories

Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.